Safety of tiotropium-olodaterol in patients with COPD & renal impairment - Video Abstract ID 161489

Video abstract of original research paper “Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONA DO® studies” published in the open access International Journal of COPD by LaForce C, Derom E, Bothner U, et al.